Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Insidious Harm of Medication Diluents as a Contributor to Cumulative Volume and Hyperchloremia: A Prospective, Open-Label, Sequential Period Pilot Study*

1. The first data on international multicenter clinical study RheoSTAT-CP0698 on the efficacy and safety of Rheosorbilact® infusion in therapy of pneumonia

   Yu. I. Feshchenko, Sophio Beridze, Dinh Thi Hoa +9

   МақолаTrauma, Hemostasis, Coagulopathy, ResuscitationInfusion & Chemotherapy20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.002368

2. The first data on international multicenter clinical study RheoSTAT-CP0691 on the efficacy and safety of Rheosorbilact® infusion in therapy of purulent peritonitis

   S Agop, V. Kh. Sharipova, K Kashibadze +7

   МақолаSepsis Diagnosis and TreatmentPerioperaciina Medicina20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.006123